| scholarly article | Q13442814 |
| P50 | author | Ronald E Gangnon | Q56810665 |
| Susan B Bressler | Q114739669 | ||
| P2093 | author name string | Barbara E K Klein | |
| Ronald Klein | |||
| Frederick L Ferris | |||
| Larry D Hubbard | |||
| Roy C Milton | |||
| Matthew D Davis | |||
| Li-Yin Lee | |||
| Age-Related Eye Disease Study Group | |||
| P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
| Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 | Q24545563 | ||
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 | Q24546140 | ||
| A simplified severity scale for age-related macular degeneration: AREDS Report No. 18 | Q34655498 | ||
| The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. | Q43796210 | ||
| Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study | Q44164361 | ||
| Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort | Q44438394 | ||
| The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study | Q45260287 | ||
| Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group | Q72093520 | ||
| The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial | Q72420867 | ||
| The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study | Q73043468 | ||
| Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group | Q73440318 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| macular degeneration | Q27429789 | ||
| P1104 | number of pages | 15 | |
| P304 | page(s) | 1484-1498 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 | |
| P478 | volume | 123 |
| Q59145971 | 3D Curvelet-Based Segmentation and Quantification of Drusen in Optical Coherence Tomography Images |
| Q33740158 | A Review of Current and Future Management of Geographic Atrophy |
| Q92456774 | A Review of Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part II |
| Q51324823 | A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration. |
| Q55435481 | A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease. |
| Q93150652 | A multi-task deep learning model for the classification of Age-related Macular Degeneration |
| Q33574618 | A short-duration dark adaptation protocol for assessment of age-related maculopathy |
| Q34655498 | A simplified severity scale for age-related macular degeneration: AREDS Report No. 18 |
| Q28655780 | A survey on computer aided diagnosis for ocular diseases |
| Q26744106 | AMD and the alternative complement pathway: genetics and functional implications |
| Q88627043 | AMISH EYE STUDY: Baseline Spectral Domain Optical Coherence Tomography Characteristics of Age-Related Macular Degeneration |
| Q40152725 | ASSOCIATION BETWEEN VISUAL FUNCTION AND SUBRETINAL DRUSENOID DEPOSITS IN NORMAL AND EARLY AGE-RELATED MACULAR DEGENERATION EYES. |
| Q57299740 | Age-related macular degeneration |
| Q82698020 | Age-related macular degeneration |
| Q36909934 | Age-related macular degeneration and the immune response: implications for therapy |
| Q33263472 | Age-related macular degeneration--emerging pathogenetic and therapeutic concepts |
| Q34626440 | Aging and vision |
| Q35056603 | Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins |
| Q34565579 | Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration |
| Q54458114 | Analysis of complement factor H Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibility to age-related macular degeneration in Hungarian patients. |
| Q33552165 | Animals as models of age-related macular degeneration: an imperfect measure of the truth |
| Q57826003 | Antecedents of Soft Drusen, the Specific Deposits of Age-Related Macular Degeneration, in the Biology of Human Macula |
| Q33634096 | Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration |
| Q98577941 | Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD |
| Q56243498 | Association Between the Cilioretinal Artery and Choroidal Neovascularization in Age-Related Macular Degeneration: A Secondary Analysis From the Age-Related Eye Disease Study |
| Q92524759 | Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39 |
| Q35429130 | Association of OCT derived drusen measurements with AMD associated-genotypic SNPs in Amish population |
| Q47335501 | Association of Rare Predicted Loss-of-Function Variants in Cellular Pathways with Sub-Phenotypes in Age-Related Macular Degeneration |
| Q50051702 | Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome. |
| Q33584512 | Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation |
| Q34003267 | Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health |
| Q90082786 | Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15 |
| Q92266156 | Automated detection and classification of early AMD biomarkers using deep learning |
| Q62490429 | Automated detection of age-related macular degeneration in color fundus photography: A systematic review |
| Q35826745 | Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration |
| Q37227482 | Automated drusen segmentation and quantification in SD-OCT images |
| Q40734890 | Automatic Screening and Grading of Age-Related Macular Degeneration from Texture Analysis of Fundus Images |
| Q38877436 | Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores |
| Q47567166 | CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation |
| Q21090046 | CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD |
| Q38818680 | CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. |
| Q38767261 | Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases |
| Q37728614 | Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials. |
| Q98188474 | Chances and challenges of machine learning-based disease classification in genetic association studies illustrated on age-related macular degeneration |
| Q34575838 | Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging |
| Q50480448 | Characteristics of fundus autofluorescence and drusen in the fellow eyes of Japanese patients with exudative age-related macular degeneration. |
| Q34691365 | Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial |
| Q54960105 | Characterization of Rod Function Phenotypes Across a Range of Age-Related Macular Degeneration Severities and Subretinal Drusenoid Deposits. |
| Q33758267 | Cholesterol in the retina: the best is yet to come. |
| Q49566059 | Choriocapillaris Vascular Density Changes in Patients with Drusen: Cross-Sectional Study Based on Optical Coherence Tomography Angiography Findings. |
| Q28551885 | Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis |
| Q92899164 | Clinical Role of Epigenetics and Network Analysis in Eye Diseases: A Translational Science Review |
| Q92647985 | Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration |
| Q26864721 | Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part II |
| Q40526474 | Clinical features and long-term progression of reticular pseudodrusen in age-related macular degeneration: findings from a multicenter cohort |
| Q37117469 | Clinical trials - more than an assessment of treatment effect: LXV Edward Jackson Memorial Lecture |
| Q37044220 | Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids |
| Q36535118 | Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular Health |
| Q36758308 | Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging |
| Q42259017 | Comparison of time domain and spectral domain optical coherence tomography in measurement of macular thickness in macular edema secondary to diabetic retinopathy and retinal vein occlusion |
| Q35118257 | Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. |
| Q35133725 | Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium |
| Q44489996 | Complement factor B polymorphism and the phenotype of early age-related macular degeneration |
| Q90675411 | Complement family member CFI polymorphisms and AMD susceptibility from a comprehensive analysis |
| Q37455410 | Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration |
| Q33953252 | Cone structure in subjects with known genetic relative risk for AMD. |
| Q52654126 | Correlation between retinal function and microstructural foveal changes in intermediate age related macular degeneration. |
| Q36283819 | Correlations between Photodegradation of Bisretinoid Constituents of Retina and Dicarbonyl Adduct Deposition |
| Q37879172 | Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures |
| Q36279801 | DYNAMISM OF DOT SUBRETINAL DRUSENOID DEPOSITS IN AGE-RELATED MACULAR DEGENERATION DEMONSTRATED WITH ADAPTIVE OPTICS IMAGING. |
| Q64080426 | Decreased uncoupling protein 2 expression in aging retinal pigment epithelial cells |
| Q91879189 | Deep-learning-based Prediction of Late Age-Related Macular Degeneration Progression |
| Q34500095 | Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration. |
| Q33676775 | Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial |
| Q34216036 | Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis |
| Q34405206 | Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. |
| Q64247384 | Dietary intervention in patients with age-related macular degeneration: protocol for a randomised controlled trial |
| Q37083770 | Diminishing risk for age-related macular degeneration with nutrition: a current view |
| Q34762448 | Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography |
| Q33565104 | Driving and Age-Related Macular Degeneration |
| Q42514513 | Drusen in patient-derived hiPSC-RPE models of macular dystrophies. |
| Q37627216 | Drusen volume development over time and its relevance to the course of age-related macular degeneration. |
| Q42237283 | Drusen, an old but new frontier |
| Q37395303 | Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging |
| Q42086363 | Effect of change in drusen evolution on photoreceptor inner segment/outer segment junction |
| Q41845904 | Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration |
| Q36391339 | Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study |
| Q34518507 | Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration |
| Q42261791 | Enhanced Detection of Sub-Retinal Pigment Epithelial Cell Layer Deposits in Human and Murine Tissue: Imaging Zinc as a Biomarker for Age-Related Macular Degeneration (An American Ophthalmological Society Thesis). |
| Q40615188 | Epidemiology of age-related macular degeneration |
| Q30239897 | Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors |
| Q33339267 | Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema |
| Q37334899 | Examining the association between age-related macular degeneration and motor vehicle collision involvement: a retrospective cohort study |
| Q36205759 | Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study |
| Q91012580 | Femtosecond Laser Pulse Ablation of Sub-Cellular Drusen-Like Deposits |
| Q35111647 | Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study |
| Q34215917 | Foveal localization in non-exudative AMD using scanning laser polarimetry |
| Q36467703 | Functional single nucleotide polymorphism in IL-17A 3' untranslated region is targeted by miR-4480 in vitro and may be associated with age-related macular degeneration |
| Q36167163 | Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization |
| Q49963850 | Genome-wide Analysis of Disease Progression in Age-related Macular Degeneration. |
| Q28074640 | Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review |
| Q26774188 | Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects |
| Q26749615 | Guidelines for the Management of Wet Age-Related Macular Degeneration: Recommendations from a Panel of Greek Experts |
| Q33643633 | Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium |
| Q38865409 | Histological and Electrophysiological Changes in the Retinal Pigment Epithelium after Injection of Sodium Iodate in the Orbital Venus Plexus of Pigmented Rats. |
| Q35897928 | Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography. |
| Q37879171 | Imaging characteristics of dry age-related macular degeneration. |
| Q98779157 | Imaging of Age-Related Macular Degeneration by Adaptive Optics Scanning Laser Ophthalmoscopy in Eyes With Aged Lenses or Intraocular Lenses |
| Q64110252 | Imaging, Genetic, and Demographic Factors Associated With Conversion to Neovascular Age-Related Macular Degeneration: Secondary Analysis of a Randomized Clinical Trial |
| Q43669289 | In Vivo Multimodal Imaging of Drusenoid Lesions in Rhesus Macaques |
| Q33848714 | In-depth analyses unveil the association and possible functional involvement of novel RAD51B polymorphisms in age-related macular degeneration |
| Q40203336 | Incidence of Intermediate-stage Age-related Macular Degeneration in Patients With Acquired Immunodeficiency Syndrome |
| Q34740219 | Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials. |
| Q36961648 | Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy |
| Q37186026 | Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration |
| Q37696572 | Infrared reflectance imaging in age-related macular degeneration |
| Q34956193 | Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial |
| Q35929970 | Is drusen area really so important? An assessment of risk of conversion to neovascular AMD based on computerized measurements of drusen |
| Q35319315 | Joint Effect of CFH and ARMS2/HTRA1 Polymorphisms on Neovascular Age-Related Macular Degeneration in Chinese Population |
| Q89831192 | Long-term Evolution and Remodeling of Soft Drusen in Rhesus Macaques |
| Q41697555 | MMP-2 Rs24386 (C-->T) gene polymorphism and the phenotype of age-related macular degeneration |
| Q36297031 | Measurement of macular pigment optical density among healthy Chinese people and patients with early-stage age-related macular degeneration |
| Q38150757 | Mechanisms of age-related macular degeneration and therapeutic opportunities |
| Q36996217 | Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) |
| Q35423355 | Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration |
| Q35293056 | Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography |
| Q34164826 | Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. |
| Q40649624 | No Sex Differences in the Frequencies of Common Single Nucleotide Polymorphisms Associated with Age-Related Macular Degeneration |
| Q37592954 | Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review |
| Q36083941 | Nutritional modulation of age-related macular degeneration. |
| Q37577219 | OCT minimum intensity as a predictor of geographic atrophy enlargement |
| Q37543563 | Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System. |
| Q36088547 | Olive Oil Consumption and Age-Related Macular Degeneration: The Alienor Study |
| Q55313056 | On the impact of different approaches to classify age-related macular degeneration: Results from the German AugUR study. |
| Q38605292 | Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration |
| Q51117668 | Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration. |
| Q98577944 | Performance of Classification Systems for Age-Related Macular Degeneration in the Rotterdam Study |
| Q33834227 | Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration |
| Q52985764 | Photoreceptor dysfunction in early and intermediate age-related macular degeneration assessed with mfERG and spectral domain OCT. |
| Q35174975 | Photoreceptor perturbation around subretinal drusenoid deposits as revealed by adaptive optics scanning laser ophthalmoscopy |
| Q35762030 | Plasma apolipoproteins and risk for age related maculopathy |
| Q90952568 | Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective |
| Q99239361 | Predicting risk of late age-related macular degeneration using deep learning |
| Q36517811 | Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy |
| Q36828388 | Prevalence of Subretinal Drusenoid Deposits in Older Persons with and without Age-Related Macular Degeneration, by Multimodal Imaging. |
| Q41227651 | Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome |
| Q90314602 | Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21 |
| Q33734035 | Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography |
| Q37344730 | Projection OCT fundus imaging for visualising outer retinal pathology in non-exudative age-related macular degeneration. |
| Q34395891 | Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration |
| Q52866840 | Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration. |
| Q44311629 | QUANTITATIVE ANALYSIS OF THE INNER RETINAL LAYER THICKNESSES IN AGE-RELATED MACULAR DEGENERATION USING CORRECTED OPTICAL COHERENCE TOMOGRAPHY SEGMENTATION. |
| Q34127143 | Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs |
| Q42511257 | Quick-freeze/deep-etch electron microscopy visualization of the mouse posterior pole |
| Q50068644 | RESIDUAL CHOROIDAL VESSELS IN ATROPHY CAN MASQUERADE AS CHOROIDAL NEOVASCULARIZATION ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY: Introducing a Clinical and Software Approach. |
| Q34307274 | Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration |
| Q37627233 | Relationship between macular pigment and visual function in subjects with early age-related macular degeneration |
| Q37626349 | Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration. |
| Q102211133 | Reproducibility of qualitative assessment of drusen volume in eyes with age related macular degeneration |
| Q51608120 | Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis. |
| Q36226963 | Retinal Pigment Epithelium Degeneration Associated With Subretinal Drusenoid Deposits in Age-Related Macular Degeneration. |
| Q34518363 | Risk characteristics of the combined geographic atrophy and choroidal neovascularisation phenotype in age-related macular degeneration. |
| Q38828895 | Risk factors and biomarkers of age-related macular degeneration |
| Q34491990 | Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. |
| Q47150018 | Risk of macular degeneration affected by polymorphisms in Matrix metalloproteinase-2: A case-control study in Chinese Han population |
| Q52326632 | Rod-Mediated Dark Adaptation and Macular Pigment Optical Density in Older Adults with Normal Maculas. |
| Q47864131 | SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration |
| Q36257030 | Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 |
| Q35482225 | Small Drusen and Age-Related Macular Degeneration: The Beaver Dam Eye Study |
| Q35230959 | Smoking, antioxidant supplementation and dietary intakes among older adults with age-related macular degeneration over 10 years |
| Q57826004 | Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies |
| Q33359481 | Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration |
| Q35085946 | Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration |
| Q36508205 | Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration |
| Q92189891 | Standardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique |
| Q46294291 | Strategies for following dry age-related macular degeneration |
| Q38975097 | Structural and molecular changes in the aging choroid: implications for age-related macular degeneration |
| Q36350410 | Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration. |
| Q34522738 | Summary results and recommendations from the age-related eye disease study |
| Q34476425 | Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration |
| Q89454097 | Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes |
| Q58594328 | The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration |
| Q37412560 | The Age-Related Macular Degeneration Complex: Linking Epidemiology and Histopathology Using the Minnesota Grading System (The Inaugural Frederick C. Blodi Lecture). |
| Q36630890 | The Association Between Subretinal Drusenoid Deposits in Older Adults in Normal Macular Health and Incident Age-Related Macular Degeneration |
| Q50110549 | The Impact of Epiretinal Membrane in Neovascular Age-Related Macular Degeneration Treatment: A Spectral-Domain Optical Coherence Tomography Study. |
| Q33624678 | The Nakuru eye disease cohort study: methodology & rationale |
| Q64079144 | The Utah Protocol for Postmortem Eye Phenotyping and Molecular Biochemical Analysis |
| Q33702571 | The complexities underlying age-related macular degeneration: could amyloid beta play an important role? |
| Q48432725 | The development & evaluation of two vision screening tools for correctable visual loss in older people |
| Q36592814 | The genetic variant rs4073 A→T of the Interleukin-8 promoter region is associated with the earlier onset of exudative age-related macular degeneration |
| Q33998365 | The retinal pigment epithelium in health and disease |
| Q54266323 | The role of MMP2 (-1306C>T) and TIMP2 (-418 G>C) promoter variants in age-related macular degeneration. |
| Q33950814 | Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples |
| Q36801990 | Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial |
| Q91640890 | Use of Deep Learning for Detailed Severity Characterization and Estimation of 5-Year Risk Among Patients With Age-Related Macular Degeneration |
| Q58589253 | Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High Risk Individuals |
| Q36069597 | Vision-targeted health related quality of life in older adults: patient-reported visibility problems in low luminance activities are more likely to decline than daytime activities |
| Q38837386 | Visual Function and Its Relationship with Severity of Early, and Activity of Neovascular, Age-Related Macular Degeneration |
| Q36848556 | Visual Function in Older Eyes in Normal Macular Health: Association with Incident Early Age-Related Macular Degeneration 3 Years Later. |
| Q33717538 | Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. |
| Q36171917 | Wnt signaling in age-related macular degeneration: human macular tissue and mouse model |
| Q80476063 | [Toward prevention of age-related macular degeneration] |
| Q81299798 | [Visual acuity after cataract surgery in patients with age-related macular degeneration] |
Search more.